Cargando…

Effectiveness and Adherence of Dry Eye Patients Who Switched from Short- to Long-Acting Diquafosol Ophthalmic Solution

Long-acting (lasting extend) diquafosol ophthalmic solution 3% (DQSLX) is administered three times daily versus six times daily for the currently approved diquafosol ophthalmic solution (DQS). We investigated the efficacy and adherence of switching from DQS to DQSLX in patients with dry eye disease....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Sho, Sasaki, Takanori, Maruyama, Takahumi, Murayama, Koichiro, Shinoda, Kei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342394/ https://www.ncbi.nlm.nih.gov/pubmed/37445527 http://dx.doi.org/10.3390/jcm12134495

Ejemplares similares

Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes
por: Koh, Shizuka
Publicado: (2015)

Modified Basket Suture for a Floppy or Irregular Iris in Endothelial Keratoplasty
por: Ishikawa, Sho, et al.
Publicado: (2023)

Short-term application of diquafosol ophthalmic solution benefits children with dry eye wearing orthokeratology lens
por: Yang, Yuanfang, et al.
Publicado: (2023)

A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients
por: Takamura, Etsuko, et al.
Publicado: (2012)

Effects of 3% diquafosol sodium ophthalmic solution on higher-order aberrations in patients diagnosed with dry eye after cataract surgery
por: Inoue, Yasushi, et al.
Publicado: (2016)

Prolonged increase in tear meniscus height by 3% diquafosol ophthalmic solution in eyes with contact lenses
por: Nagahara, Yukiko, et al.
Publicado: (2015)

Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease
por: Mun, Yongseok, et al.
Publicado: (2018)

The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study
por: Chen, Jiayan, et al.
Publicado: (2023)

Efficacy and Safety of the Long-Acting Diquafosol Ophthalmic Solution DE-089C in Patients with Dry Eye: A Randomized, Double-Masked, Placebo-Controlled Phase 3 Study
por: Hori, Yuichi, et al.
Publicado: (2022)

Correction: The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study
por: Chen, Jiayan, et al.
Publicado: (2023)

Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis
por: Wang, Tianjiao, et al.
Publicado: (2023)

Long-term Rebamipide and Diquafosol in Two Cases of Immune-Mediated Dry Eye
por: Yamane, Mio, et al.
Publicado: (2015)

Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
por: Amano, Shiro, et al.
Publicado: (2017)

Effect of Diquafosol Ophthalmic Solution on Airflow-Induced Ocular Surface Disorder in Diabetic Rats
por: Dota, Atsuyoshi, et al.
Publicado: (2020)

Comparison of matrix metallopeptidase-9 expression following cyclosporine and diquafosol treatment in dry eye
por: So, Ha Rim, et al.
Publicado: (2023)

3% diquafosol sodium eye drops in Chinese patients with dry eye: a phase IV study
por: Wang, Wenying, et al.
Publicado: (2023)

Proportion and characteristics of lacrimal drainage pathway disease and keratopathy in non-infectious corneal perforation using lacrimal syringing test
por: Ishikawa, Sho, et al.
Publicado: (2023)

Tear volume estimation using a modified Schirmer test: a randomized, multicenter, double-blind trial comparing 3% diquafosol ophthalmic solution and artificial tears in dry eye patients
por: Miyake, Hideki, et al.
Publicado: (2016)

Protocol for a parallel assignment prospective, randomised, comparative trial to evaluate the safety and efficacy of intense pulsed light (IPL) combined with 3% diquafosol (DQS) ophthalmic solution in dry eye syndrome
por: Chen, Jiayan, et al.
Publicado: (2023)

Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser-Assisted Cataract Surgery
por: Yamazaki, Kenichiro, et al.
Publicado: (2022)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2019)

Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials
por: Liu, Shuang, et al.
Publicado: (2023)

Diquafosol ophthalmic solution enhances mucin expression via ERK activation in human conjunctival epithelial cells with hyperosmotic stress
por: Lee, Hyun Jung, et al.
Publicado: (2022)

Safety and efficacy of pilocarpine, cevimeline, and diquafosol compared to artificial tears for the treatment of dry eye: protocol for a systematic review
por: Serrano-Robles, José Gerardo, et al.
Publicado: (2022)

Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2020)

Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes
por: Shrivastava, Saurabh, et al.
Publicado: (2018)

Effect of a single warm compress prior to ophthalmic surgery on ocular surface and intraoperative visibility: a randomised controlled study
por: Ishikawa, Sho, et al.
Publicado: (2023)

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)

Long-Term Safety and Effectiveness of Diquafosol for the Treatment of Dry Eye in a Real-World Setting: A Prospective Observational Study
por: Ohashi, Yuichi, et al.
Publicado: (2019)

Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study
por: Miyake, Kensaku, et al.
Publicado: (2017)

Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
por: White, Darrell E, et al.
Publicado: (2019)

Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease
por: de Oliveira, Rodrigo Carlos, et al.
Publicado: (2019)

Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial
por: Jun, Ikhyun, et al.
Publicado: (2019)

Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study
por: Fukuoka, Shima, et al.
Publicado: (2019)

Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials
por: Zhao, Xinyu, et al.
Publicado: (2017)

Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study
por: Lee, Kwan Bok, et al.
Publicado: (2017)

Real-world treatment patterns of OTX-101 ophthalmic solution, cyclosporine ophthalmic emulsion, and lifitegrast ophthalmic solution in patients with dry eye disease: a retrospective analysis
por: Karpecki, Paul, et al.
Publicado: (2023)

Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye
por: Nguyen, Theresa, et al.
Publicado: (2011)

Irrational ophthalmic fixed-dose combinations for dry eye syndrome
por: Kshirsagar, Nilima A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nmk8ru79oojp3bbm7scjmkrnu7